Latest filing published 11 Feb 2021 for BIOTELEMETRY, INC., €4.9M.
No signal scores available.
This profile gathers the share dealings of Stephen Rietiker in Biotelemetry, Inc. Between 18 January 2019 and 9 February 2021, the trades on record add up to 4 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 11 February 2021, the filings show a transaction worth €4.9M in Biotelemetry, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations